(Q37421191)

20 August 2017

1 reference

title

Urocortin: a protective peptide that targets both the myocardium and vasculature (English)

1 reference

20 August 2017

1

Sean M Davidson

1 reference

20 August 2017

Derek M Yellon

2

1 reference

PubMed ID

19307705

20 August 2017

language of work or name

1 reference

1 January 2009

1 reference

20 August 2017

Pharmacological Reports

1 reference

20 August 2017

61

1 reference

20 August 2017

1

1 reference

20 August 2017

172-182

1 reference

Influence of urocortin and corticotropin releasing factor on venous tone in conscious rats

20 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Peripheral corticotropin-releasing hormone and urocortin in the control of the immune response

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Corticotropin-releasing factor receptor 2 is a tonic suppressor of vascularization

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

The cardiovascular physiologic actions of urocortin II: acute effects in murine heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Studies of the role of endothelium-dependent nitric oxide release in the sustained vasodilator effects of corticotrophin releasing factor and sauvagine

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heart.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Urocortin protects against ischemic and reperfusion injury via a MAPK-dependent pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Activation of protein kinase B/Akt by urocortin is essential for its ability to protect cardiac cells against hypoxia/reoxygenation-induced cell death

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Divergent effects of corticotropin releasing hormone on endothelial cell nitric oxide synthase are associated with different expression of CRH type 1 and 2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Hypertrophic effects of urocortin homologous peptides are mediated via activation of the Akt pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Urocortin 1 exhibits potent inhibition of cardiac sympathetic nerve activity in conscious sheep

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Plasma urocortin 1 in sheep: regional sampling and effects of experimental heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Urocortin II gene is highly expressed in mouse skin and skeletal muscle tissues: localization, basal expression in corticotropin-releasing factor receptor (CRFR) 1- and CRFR2-null mice, and regulation by glucocorticoids.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Central stresscopin modulates cardiovascular function through the adrenal medulla in conscious rats

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Binding of [125I]Tyr-corticotropin-releasing factor to rabbit aorta is reduced by removal of the endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

The powerful cardioprotective effects of urocortin and the corticotropin releasing hormone (CRH) family

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Urocortin 2 infusion in healthy humans: hemodynamic, neurohormonal, and renal responses

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Urocortin 2 infusion in human heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Effect of urocortin 1 infusion in humans with stable congestive cardiac failure

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Urocortin-1 infusion in normal humans

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Corticotropin-releasing factor (CRF) can directly affect brain microvessel endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Corticotropin-releasing factor (CRF): mechanism to elevate mean arterial pressure and heart rate

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Mechanisms of the protective effects of urocortin on coronary endothelial function during ischemia-reperfusion in rat isolated hearts.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Urocortin protects coronary endothelial function during ischemia-reperfusion: a brief communication.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

A comparison between the cardiovascular actions of urocortin 1 and urocortin 2 (stresscopin-related peptide) in conscious rats

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

The effect of urocortin II administration on the coronary circulation and cardiac function in the anaesthetized pig is nitric-oxide-dependent

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Urocortin2 inhibits tumor growth via effects on vascularization and cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Survival kinases in ischemic preconditioning and postconditioning.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Hypotensive effects of ovine and human corticotrophin-releasing factors in man

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

The molecular mechanisms underlying the regulation of the biological activity of corticotropin-releasing hormone receptors: implications for physiology and pathophysiology.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Endothelial urocortin has potent antioxidative properties and is upregulated by inflammatory cytokines and pitavastatin

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Urocortin-induced endothelium-dependent relaxation of rat coronary artery: role of nitric oxide and K+ channels.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Urocortin has cell-proliferative effects on cardiac non-myocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Effects of urocortin II on neonatal rat cardiac myocytes and non-myocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Urocortin, a newly identified corticotropin-releasing factor-related mammalian peptide, stimulates atrial natriuretic peptide and brain natriuretic peptide secretions from neonatal rat cardiomyocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Expression of receptors for corticotropin-releasing factor in the vasculature of pregnant rats

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Expression of urocortin and corticotropin-releasing factor receptor subtypes in the human heart

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Cardiac release of urocortin precedes the occurrence of irreversible myocardial damage in the rat heart exposed to ischemia/reperfusion injury

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

The Urocortins: mechanisms of cardioprotection and therapeutic potential

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Relaxing actions of corticotropin-releasing factor on rat resistance arteries.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Urocortin ameliorates diabetic nephropathy in obese db/db mice

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Plasma urocortin in human systolic heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Urocortin, a member of the corticotropin-releasing factor family, in normal and diseased heart

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Expression and protective effects of urocortin in cardiac myocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Urocortin and the brain

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Cardiac inotropic actions of urocortin in conscious sheep

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Cardiovascular actions of CRH and urocortin: an update

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Integrated hemodynamic, hormonal, and renal actions of urocortin 2 in normal and paced sheep: beneficial effects in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Urocortin 3: haemodynamic, hormonal, and renal effects in experimental heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Beneficial hemodynamic, endocrine, and renal effects of urocortin in experimental heart failure: comparison with normal sheep

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Endogenous urocortins reduce vascular tone and renin-aldosterone/endothelin activity in experimental heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Cardiotrophin-1 and urocortin cause protection by the same pathway and hypertrophy via distinct pathways in cardiac myocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Urocortin promotes hemodynamic and bioenergetic recovery and improves cell survival in the isolated rat heart exposed to ischemia/reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Characterization of the relaxant action of urocortin, a new peptide related to corticotropin-releasing factor in the rat isolated basilar artery

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Urocortin protects the heart from reperfusion injury via upregulation of p42/p44 MAPK signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Human umbilical vein endothelial cells: a new source and potential target for corticotropin-releasing factor

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Expression of urocortin III/stresscopin in human heart and kidney

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Coronary vasodilation and positive inotropism by urocortin in the isolated rat heart

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Urocortin prevents mitochondrial permeability transition in response to reperfusion injury indirectly by reducing oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Hemodynamic effects of corticotropin releasing hormone in the anesthetized cynomolgus monkey

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Effects of corticotropin-releasing hormone (CRH) on endothelin-1 and NO release, mediated by CRH receptor subtype R2: a potential link between stress and endothelial dysfunction?

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

CRF2 receptors are highly expressed in the human cardiovascular system and their cognate ligands urocortins 2 and 3 are potent vasodilators

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Urocortin: a beneficial or detrimental agent to endothelium?

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Effects of intravenous urocortin on angiotensin-converting enzyme in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Urocortin II enhances contractility in rabbit ventricular myocytes via CRF(2) receptor-mediated stimulation of protein kinase A.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

Endothelium-dependent and -independent coronary relaxation induced by urocortin

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970019-2

7 January 2021

10.1016/S1734-1140(09)70019-2

Identifiers

DOI

1 reference

20 August 2017

1 reference

PubMed ID

19307705